Gregory J. Cunn, MD

Ticagrelor vs Clopidogrel in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention: Insights From a Single Institution Registry

07/14/2019

Sorin J. Brener , MD;

Terrence J. Sacchi , MD;

Venkatesh Alapati , MD;

Max M. Benson , MD;

Doris Chan , DO;

Gregory J. Cunn , MD;

Saadat Khan , MD;

Issa Kutkut , MD;

John P. O'Laughlin , MD;

Chockalingham Arun Narayanan , MD;

We identified ACS patients from our institutional registry who underwent PCI and received either ticagrelor or clopidogrel and compared 1-year all-cause death rates.

We identified ACS patients from...

07/14/2019

Journal of Invasive Cardiology

A Novel Risk Score to Predict One-Year Mortality in Patients Undergoing Complex High-Risk Indicated Percutaneous Coronary Intervention (CHIP-PCI)

04/01/2021

Terrence J. Sacchi , MD;

Gregory J. Cunn , MD;

Issa Kutkut , MD;

Pankil H. Desai , MD;

Mouzamjha Faroqui , MD;

Sorin J. Brener , MD;

Le Dung Ha , MD;

Garima Handa , MD;

Adnan Raza , MD;

Our aim was to identify patients undergoing complex, high-risk indicated percutaneous coronary intervention (CHIP-PCI) and compare their outcomes with non-CHIP patients. We created a CHIP score to risk stratify these patients.

Our aim was to identify patients...

04/01/2021

Journal of Invasive Cardiology